Accelerating a Cancer Cure

The National Foundation for Cancer Research (NFCR), AIM-HI, and GoMo Health are collaborating to make it easier for people worldwide to discover and qualify for clinical trials that could be very helpful to them or a loved one who has cancer.

Find a Trial
Learn More About Us

Are you a…

Trial Participant

Start here

Pharmaceutical or Biotech Company

Start here

Provider or Potential Investigator

Start here

Featured Trials

Sparta Trial Logo: Researching Ways to Battle Cancer

SPARTA/APL-101 Study

The goal of the SPARTA study is to learn if an investigational drug, called APL-101, can help patients with non-small cell lung cancer (NSCLC) or other advanced solid tumors with a genetic alteration in c-Met oncogene (such as amplification, fusion, or EXON 14 skipping mutation). Other advanced solid tumors include, but are not limited to, brain, head and neck, gastric, esophageal, biliary, pancreatic, or colorectal cancer.

Learn more
CALM Clinical Trial Logo

CALM/YIV-906 Study

Yiviva has launched a research study to investigate whether adding YIV-906 (the study drug), comprised of four naturally derived ingredients (licorice, skullcap, peony, and dates) to sorafenib (a currently available, typical treatment for liver cancer) can increase the length of time patients with hepatocellular carcinoma (HCC) live with their disease before it worsens. The evidence-based study drug is developed from an 1800-year-old Chinese formula.

Learn more

Improving Clinical Trial Awareness and Recruitment

Microscope laboratory - woman medical research

Learn how the collaboration between The National Foundation for Cancer Research (NFCR) and GoMo Health aims to make it easier for people to discover and qualify for clinical trials.

Learn More »